Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
Actual shortage: | 217 (6%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 335 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2023-11-10 | 2024-01-19 | 209910 |
APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209913 |
APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209916 |
APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2023-11-10 | 2024-01-19 | 209919 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2022-11-18 | 2022-12-05 | 175299 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2022-11-20 | 2022-12-02 | 175309 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2025-03-13 | 2025-04-04 | 252554 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2017-06-13 | 2017-07-17 | 12668 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2018-05-22 | 2018-09-08 | 49967 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2018-08-09 | 2018-10-13 | 57772 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221726 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2017-09-26 | 2017-11-07 | 23536 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2017-12-19 | 2018-07-03 | 33783 |
APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-12-19 | 2018-07-04 | 33780 |
APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-06-26 | 2017-07-17 | 13970 |
APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-07-26 | 2017-11-07 | 17202 |
APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-07-26 | 2017-10-24 | 17205 |
APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2021-06-25 | 2021-10-05 | 141526 |
APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2023-05-26 | 2023-07-13 | 193203 |
APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2018-05-22 | 2018-09-09 | 49970 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |